Today's Rundown Pfizer posts detailed phase 3 data on its Dupixent rival BridgeBio scraps plan to buy Eidos after bids rebuffed ReNeuron shares clinical data on stem cell vision loss therapy [Sponsored] A New Starting Point for Patient Support: Technology-Driven Hub Services CAR-T cells as 'bait' show promise in autoimmune diseases Covance clinical development lead takes the reins at Pharm-Olam Featured Story | | | Saturday, October 12, 2019 Pfizer has posted detailed phase 3 results on its rival to Sanofi and Regeneron’s atopic dermatitis drug Dupixent. The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent for a major market. |
|
|---|
|
Top Stories Monday, October 14, 2019 BridgeBio Pharma has scrapped plans to buy out its subsidiary Eidos Therapeutics. The planned deal hit a wall when a special committee set up by Eidos turned down BridgeBio’s third and final offer. Monday, October 14, 2019 ReNeuron has presented detailed data from a phase 1/2a clinical trial of its stem cell treatment for retinitis pigmentosa. Shares in ReNeuron fell more than one-third after the release of top-line data at the start of the month, but the biotech argued the detailed results are positive for its prospects. Monday, October 14, 2019 Flipping the script for specialty medications – improved patient access and time-to-therapy with a new tech-enabled platform from CoverMyMeds and RxCrossroads by McKesson. Monday, October 14, 2019 By using CAR-T therapy's idea of modifying T cells to target diseased cells, scientists at the University of Pennsylvania have developed chimeric autoantigen receptor (CAAR) T cells to specifically eliminate B cells that are responsible for autoimmune diseases. Monday, October 14, 2019 As Covance changes up its leadership amid a major change at the top of its parent company, one of its former execs has jumped ship to midsize rival CRO Pharm-Olam. | | Experts in our field; with 20+ years of experience in Viral Vector and plasmid DNA (R&D, High Quality and GMP) manufacture for pre-clinical, clinical and commercial supply. Take a virtual tour of our facilities and find out more about our most recent expansion project. |
Resources Sponsored by: Outer Edge Technology Companies that don’t have a cloud strategy are at a competitive disadvantage. Why? The cloud has a measurable impact on business. Sponsored by: Medidata Simplified filing, improved oversight, audit readiness: is your eTMF system delivering best-in-class benefits? Sponsored by: Colorcon® Learn about how you better manage product authentication and battle drug counterfeiting with innovative solutions. Sponsored by: Cortellis, a Clarivate Analytics Solution Download this report for full details of Life sciences M&As in the second quarter of 2019 with notes and trends. Sponsored by: Elligo Health Research Find out how it leverages real-world data and novel IntElligo Research Stack™ technology to help researchers battle rising costs, cumbersome processes, and stagnant participation — bridging the gap between research and care. Sponsored by: InformedDNA Download this complimentary guide paper that explores key strategies for a successful genetics-informed clinical trial. Sponsored by: Life Image The time has finally come when medical imaging can be effectively utilized into the RWE process. Read the whitepaper on the best practices for incorporating Real World Imaging.™ Sponsored by: Patheon, by Thermo Fisher Scientific Is your API development on track? Sponsored by: BioAnalytix, Inc. Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: ON24 Compare digital program performance and audience engagement among your life sciences peers. Sponsored by: Decision Resources Group Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem. Sponsored by: Reprints Desk, Inc. Slashing your R&D costs is easier than you think. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Countdown to Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register Now at www.drugstomarket.com/drugbootcamp and start Pre-Boot Camp Preparation | 